Ratings by RBC Capital (Randall Stanicky)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2021 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2021 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2021 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/1/2021 | Endo International plc | ENDP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/1/2021 | Amneal Pharmaceuticals | AMRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/26/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2021 | Viatris | VTRS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2021 | Abbvie | ABBV | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/1/2021 | Pfizer | PFE | Maintain | Sector Perform (Sector Perform) |
|
Details | ||
| 1/7/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/6/2021 | Perrigo Co. | PRGO | Downgrade | Sector Perform (Outperform) |
44.27 (13.91) |
-68.58% | Details | |
| 12/16/2020 | Pfizer | PFE | Downgrade | Sector Perform (Outperform) |
38.71 (27.95) |
-27.8% | Details | |
| 12/15/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2020 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Endo International plc | ENDP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2020 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/1/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/25/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2020 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/3/2020 | Pfizer | PFE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2020 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Evofem Biosciences Inc | EVFM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2020 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | Perrigo Co. | PRGO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2020 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/20/2020 | Abbvie | ABBV | Upgrade | Outperform (Sector Perform) |
83.45 (265.77) |
218.48% | Details | |
| 4/1/2020 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/1/2020 | Perrigo Co. | PRGO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2020 | Pfizer | PFE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2020 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2020 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2020 | Abbvie | ABBV | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/24/2020 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/23/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2020 | Perrigo Co. | PRGO | Upgrade | Outperform (Sector Perform) |
49.63 (13.91) |
-71.97% | Details | |
| 3/3/2020 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/28/2020 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2020 | Endo International plc | ENDP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/26/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2020 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2020 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/10/2020 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/10/2020 | Abbvie | ABBV | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/6/2020 | Merck | MRK | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/3/2020 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/24/2020 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/24/2020 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2020 | Abbvie | ABBV | New Coverage | Sector Perform (N/A) |
88.70 (83.45) |
-5.92% | Details | |
| 1/7/2020 | Pfizer | PFE | New Coverage | Outperform (N/A) |
38.93 (38.71) |
-0.57% | Details | |
| 1/7/2020 | Merck | MRK | New Coverage | Sector Perform (N/A) |
91.25 (152.09) |
66.67% | Details | |
| 1/6/2020 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/2/2020 | Amneal Pharmaceuticals | AMRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/19/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Assertio Therapeutics | ASRT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/31/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2019 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/29/2019 | Agile Therapeutics | AGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2019 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/13/2019 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/9/2019 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Assertio Therapeutics | ASRT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/31/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/11/2019 | Endo International plc | ENDP | Downgrade | Sector Perform (Outperform) |
4.30 (0.29) |
-93.26% | Details | |
| 7/11/2019 | Amneal Pharmaceuticals | AMRX | Downgrade | Sector Perform (Outperform) |
6.81 (18.02) |
164.61% | Details | |
| 6/26/2019 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/19/2019 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/30/2019 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/30/2019 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/10/2019 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | AcelRx Pharmaceuticals | ACRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Allergen | AGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2019 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2019 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/28/2019 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2019 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/18/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2019 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/8/2019 | INSYS Therapeutics | INSY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2019 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/28/2019 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2019 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/6/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2019 | Allergen | AGN | Downgrade | Sector Perform (Outperform) |
158.69 (193.02) |
21.63% | Details | |
| 1/9/2019 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/4/2019 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/31/2018 | Amneal Pharmaceuticals | AMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2018 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/26/2018 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/12/2018 | Osmotica | OSMT | New Coverage | Outperform (N/A) |
8.70 (1.11) |
-87.24% | Details | |
| 11/9/2018 | Perrigo Co. | PRGO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/9/2018 | Endo International plc | ENDP | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2018 | Teva Pharma | TEVA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2018 | Eagle Pharmaceuticals | EGRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2018 | Allergen | AGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2018 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/19/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/21/2018 | Akorn | AKRX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/20/2018 | Aquestive Therapeutics | AQST | New Coverage | Outperform (N/A) |
16.10 (4.66) |
-71.06% | Details | |
| 8/13/2018 | Endo International plc | ENDP | Upgrade | Outperform (Sector Perform) |
15.83 (4.30) |
-72.84% | Details | |
| 8/13/2018 | Amneal Pharmaceuticals | AMRX | Upgrade | Outperform (Sector Perform) |
20.14 (6.81) |
-66.19% | Details | |
| 8/13/2018 | Mylan | MYL | Upgrade | Outperform (Sector Perform) |
36.61 (15.86) |
-56.68% | Details |
